Medicine and Dentistry
Acute Kidney Injury
33%
Bladder Cancer
35%
Carcinogenicity
66%
Castration Resistant Prostate Cancer
33%
Cell Damage
33%
Cystectomy
33%
Diabetes
33%
Dilation Procedure
33%
Disease
45%
Disease Exacerbation
28%
Erectile Dysfunction
37%
Extracorporeal
33%
Extracorporeal Shock Wave Lithotripsy
33%
Extracorporeal Shockwave Therapy
33%
Focal Segmental Glomerulosclerosis
33%
Genitourinary System
33%
Growth Differentiation Factor 15
33%
Hemostat
33%
Hernioplasty
33%
In Vitro
28%
Injury
48%
Isotopes of Calcium
33%
Mediator Complex
33%
Meta-Analysis
33%
Metastatic Carcinoma
49%
Microhematuria
33%
Neobladder
33%
Neoplasm
33%
Oncology
33%
Operation Duration
41%
Percutaneous Nephrolithotomy
66%
Phosphodiesterase V Inhibitor
38%
Postoperative Pain
31%
Prostate Cancer
66%
Randomized Clinical Trial
66%
Recurrent Disease
55%
Stent Placement
58%
Subgroup Analysis
33%
Surgical Anastomosis
33%
Symptom
33%
Systematic Review
33%
Testosterone Metabolism
25%
Transitional Cell Carcinoma
66%
Treatment Response
78%
Upregulation
71%
Urethra Stenosis
33%
Urethrotomy
33%
Urinary System
33%
Urolithiasis
44%
Vardenafil
33%
Pharmacology, Toxicology and Pharmaceutical Science
ABCC1
16%
Acute Kidney Failure
33%
Androgen
38%
Biochemical Recurrence
33%
Biological Marker
12%
Bladder Cancer
35%
Cancer Prognosis
33%
Carcinogenicity
66%
Castration Resistant Prostate Cancer
33%
Chronic Prostatitis
33%
Disease
40%
Disease Exacerbation
36%
Disease Free Survival
9%
Docetaxel
16%
Doxorubicin
12%
Drug Resistance
16%
Dutasteride
16%
Focal Glomerulosclerosis
33%
Growth Differentiation Factor 15
33%
Hematoma
13%
Hernia
33%
Homo sapiens
11%
Kruppel Like Factor 4
16%
Lymph Node Metastasis
9%
Malignant Neoplasm
26%
Mediator Complex
33%
Metastasis
7%
Mouse Model
36%
Multidrug Resistance Protein 1
16%
Neoplasm
42%
Overall Survival
26%
Pelvis Pain Syndrome
33%
Phosphodiesterase V Inhibitor
33%
Postoperative Pain
20%
Prospective Study
13%
Prostate Cancer
100%
Randomized Controlled Trial
13%
Recurrent Disease
53%
Retrospective Study
13%
Seroma
13%
Short Hairpin RNA
9%
Surgical Infection
13%
Symptom
8%
Tamsulosin
23%
Therapeutic Effect
8%
Therapy Resistance
9%
Transcriptome
8%
Transitional Cell Carcinoma
66%
Tumor Necrosis Factor Receptor Associated Factor 2
33%
Vardenafil
33%
Biochemistry, Genetics and Molecular Biology
Allele
13%
Cancer Staging
8%
Cell Damage
33%
Cell Proliferation
6%
Cochrane Library
6%
Disease Free Survival
11%
down Regulation
13%
Drive
6%
E2F1
33%
E2F4
5%
Embase
6%
Gene Expression Profiling
6%
Genetic Model
20%
Genetics
33%
Gleason Score
5%
Growth Differentiation Factor
33%
Inflammatory Cytokine
11%
Interleukin 6
33%
Interleukin 8
33%
Mediator
6%
Mediator Complex
33%
Medline
6%
Overall Survival
14%
Progression Free Survival
5%
Promoter Region
38%
Small Hairpin RNA
8%
SRD5A1
33%
Survival Rate
5%
Testosterone Metabolism
11%
TRAF2
33%
Transactivation
5%
Transcription
7%
Transcriptome
10%
Upregulation
37%
Web of Science
6%
